Coronavirus disease 2019 morbid pulmonary pathology: What did we learn from autopsy examinations?
Background: Despite the rapidly expanding data on clinical, epidemiological and radiological aspects of Coronavirus Disease 2019 (COVID-19), little is known about the disease's pathological aspects. The scarcity of pathological data on COVID-19 can be explained by the limited autopsy procedures performed on deceased patients.
Aim: This work aims to review and summarize the pulmonary pathological findings observed in COIVD-19 deceased individuals based on recent case series reports published in English up to September 2020.
Methods: A search in Google Scholar, PubMed, MEDLINE and Scopus was performed using the keywords "autopsy and COVID-19", "post-mortem and COVID-19", "pulmonary/lung pathology and COVID-19".
Results: Pulmonary autopsy hallmark findings of COVID-19 cases demonstrate the presence of diffuse alveolar damage. The presence of pulmonary thrombi was reported in the majority of patients. Cellular alterations included type 2 pneumocyte hyperplasia, inflammatory cell infiltrates predominantly by lymphocytes, other mononuclear cells and neutrophils as evident by their specific immunohistochemical markers. Electron microscopy confirmed the presence of virus particles in different cell types, including type 1 and 2 pneumocytes.
Conclusion: The few emerging autopsy reports have substantially contributed towards our understanding of COVID-19 pulmonary histopathological aspects. COVID-19 caused acute severe respiratory manifestations that are the leading cause of morbidity and mortality in infected patients. More studies and research are needed to understand the inflammatory processes and histopathological changes associated with COVID-19 in African populations.
Relevance for patients: Post-mortem investigations advance important mechanistic knowledge on COVID-19 pathophysiology and clinical outcomes and could facilitate provisions for targeted therapies.
[1] Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol 2020;153:725-33.
[2] Tzankov A, Jonigk D. Unlocking the Lockdown of Science and Demystifying COVID-19: How Autopsies Contribute to our Understanding of a Deadly Pandemic. Virchows Arch 2020;477:331-3.
[3] Pomara C, Li Volti G, Cappello F. COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy! J Clin Med 2020;9:1259.
[4] Aljerian K, BaHammam AS. COVID-19: Lessons in Laboratory Medicine, Pathology, and Autopsy. Ann Thorac Med 2020;15:138-45.
[5] Bian XW, COVID-19 Pathology Team. Autopsy of COVID-19 Patients in China. Natl Sci Rev 2020;7:1414-8.
[6] Zhou B, Zhao W, Feng R, Zhang X, Li X, Zhou Y, et al. The Pathological Autopsy of Coronavirus Disease 2019 (COVID-2019) in China: A Review. Pathog Dis 2020;78:ftaa026.
[7] Barth RF, Buja LM, Parwani AV. The Spectrum of Pathological Findings in Coronavirus Disease (COVID-19) and the Pathogenesis of SARS-CoV-2. Diagn Pathol 2020;15:85.
[8] Mao Y, Lin W, Wen J, Chen G. Clinical and Pathological Characteristics of 2019 Novel Coronavirus Disease (COVID-19): A Systematic Reviews, medRxiv; 2020.
[9] Edler C, Schröder AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, et al. Dying with SARS-CoV-2 Infection-an Autopsy Study of the First Consecutive 80 Cases in Hamburg, Germany. Int J Legal Med 2020;134:1275-84.
[10] Calabrese F, Pezzuto F, Fortarezza F, Hofman P, Kern I, Panizo A, et al. Pulmonary Pathology and COVID-19: Lessons from Autopsy. The Experience of European Pulmonary Pathologists. Virchows Arch 2020;477:359-72.
[11] Polak SB, van Gool IC, Cohen D, von der Thüsen JH, van Paassen J. A Systematic Review of Pathological Findings in COVID-19: A Pathophysiological Timeline and Possible Mechanisms of Disease Progression. Mod Pathol 2020;33:2128-38.
[12] Buja LM, Wolf DA, Zhao B, Akkanti B, McDonald M, Lelenwa L, et al. The Emerging Spectrum of Cardiopulmonary Pathology of the Coronavirus Disease 2019 (COVID-19): Report of 3 Autopsies from Houston, Texas, and Review of Autopsy Findings from Other United States Cities. Cardiovasc Pathol 2020;48:107233.
[13] Youd E, Moore L. COVID-19 Autopsy in People who Died in Community Settings: The First Series. J Clin Pathol 2020;73:840-4.
[14] Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, et al. Pulmonary Arterial Thrombosis in COVID-19 with Fatal Outcome: Results from a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med 2020;173:350-61.
[15] Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy Findings and Venous Thromboembolism in Patients with COVID-19: AProspective Cohort Study. Ann Intern Med 2020;173:268-77.
[16] Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, et al. Megakaryocytes and PlateletFibrin Thrombi Characterize Multi-Organ Thrombosis at Autopsy in COVID-19: A Case Series. EClinicalMedicine 2020;24:100434.
[17] Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, et al. Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections in Washington State: A Case Series. Lancet 2020;396:320-32.
[18] Fox SE, Akmatbekov A, Harbert JL, Li G, Brown JQ, Vander Heide RS. Pulmonary and Cardiac Pathology in African American Patients with COVID-19: An Autopsy
[19] Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary Post-Mortem Findings in a Series of COVID-19 Cases from Northern Italy: A Two-Centre Descriptive Study. Lancet Infect Dis 2020;20:1135-40.
[20] Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N Engl J Med 2020;383:120-8.
[21] Bösmüller H, Traxler S, Bitzer M, Häberle H, Raiser W, Nann D, et al. The evolution of Pulmonary Pathology in Fatal COVID-19 Disease: An Autopsy Study with Clinical Correlation. Virchows Arch 2020;477:349-57.
[22] Mansueto G. COVID-19: Brief Check through the Pathologist’s Eye (Autopsy Archive). Pathol Res Pract 2020;216:153195.
[23] Borczuk AC, Salvatore SP, Seshan SV, Patel SS, Bussel JB, Mostyka M, et al. COVID-19 Pulmonary Pathology: A Multi-Institutional Autopsy Cohort from Italy and New York City. Mod Pathol 2020;33:2156-68.
[24] Beigmohammadi MT, Jahanbin B, Safaei M, Amoozadeh L, Khoshavi M, Mehrtash V, et al. Pathological Findings of Postmortem Biopsies from Lung, Heart, and Liver of 7 Deceased COVID-19 Patients. Int J Surg Pathol 2020;29:135-45.
[25] Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological Study of the 2019 Novel Coronavirus Disease (COVID-19) Through Postmortem Core Biopsies. Mod Pathol 2020;33:1007-14.
[26] Wang XX, Shao C, Huang XJ, Sun L, Meng LJ, Liu H, et al. Histopathological Features of Multiorgan Percutaneous Tissue Core Biopsy in Patients with COVID-19. J Clin Pathol 2020;74:522-7.
[27] Mansueto G, Niola M, Napoli C. Can COVID 2019 Induce a Specific Cardiovascular Damage or it Exacerbates Pre-Existing Cardiovascular Diseases? Pathol Res Pract 2020;216:153086.
[28] Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular Involvement during COVID-19 and Clinical Implications in Elderly Patients. A Review. Ann Med Surg (Lond) 2020;57:236-43.
[29] Fisicaro F, di Napoli M, Liberto A, Fanella M, di Stasio F, Pennisi M, et al. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health 2021;18:1415.
[30] Napoli C, Tritto I, Mansueto G, Coscioni E, Ambrosio G. Immunosenescence Exacerbates the COVID-19. Arch Gerontol Geriatr 2020;90:104174.